Showing 1 - 19 results of 19 for search 'Maria Teresa Gomez Casares', query time: 0.07s
Refine Results
-
1
Positive impact of eculizumab therapy on surgery for Budd- Chiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria and a longterm history of thrombosis by Silvia De-la-Iglesia, Hugo Luzardo, Angelina Lemes, Melissa Torres, Maria Teresa Gómez-Casares, Naylen Cruz, Teresa Molero
Published 2016-09-01
Article -
2
Critical review of clinical data and expert-based recommendations for the use of bosutinib in the treatment of chronic myeloid leukemia by Valentín García-Gutiérrez, María Teresa Gómez-Casares, Blanca Xicoy, Felipe Casado-Montero, Guillermo Orti, Pilar Giraldo, Juan Carlos Hernández-Boluda
Published 2024-08-01
Article -
3
Cost-effectiveness of Ruxolitinib vs Best Available Therapy in the Treatment of Myelofibrosis in Spain by María Teresa Gómez-Casares, Juan Carlos Hernández-Boluda, Antonio Jiménez-Velasco, Joaquin Martínez-López, María Giovanna Ferrario, Irmina Gozalbo, Joana Gostkorzewicz, Rudi Subirá
Published 2017-11-01
Article -
4
High resolution melting analysis: a rapid and accurate method to detect CALR mutations. by Cristina Bilbao-Sieyro, Guillermo Santana, Melania Moreno, Laura Torres, Gonzalo Santana-Lopez, Carlos Rodriguez-Medina, María Perera, Beatriz Bellosillo, Silvia de la Iglesia, Teresa Molero, Maria Teresa Gomez-Casares
Published 2014-01-01
Article -
5
PB1893: CLONAL EVOLUTION WITH BCL-2 AMPLIFICATION DURING VENETOCLAX TREATMENT by Jorge Rodríguez-Afonso, Paula Reyes-González-Casanova, Miguel Ángel Perera Álvarez, Cristina Bilbao, Ruth Stuckey, Juan Francisco Rodríguez López, Carlos Rodriguez Medina, Yanira Florido Ortega, Antonia Cionfrini, Santiago Sánchez Sosa, Maria Teresa Gomez Casares
Published 2023-08-01
Article -
6
Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study by Rosa Ayala, Rafael Alonso Fernández, Valentín García‐Gutiérrez, Alberto Alvarez‐Larrán, Santiago Osorio, Jose M. Sánchez‐Pina, Gonzalo Carreño‐Tarragona, Noemi Álvarez, María Teresa Gómez‐Casares, Antonia Duran, Julian Gorrochategi, Juan Carlos Hernández‐Boluda, Joaquín Martínez‐López
Published 2023-05-01
Article -
7
<i>BCL2</i> Expression at Post-Induction and Complete Remission Impact Outcome in Acute Myeloid Leukemia by Cristina Bilbao-Sieyro, Carlos Rodríguez-Medina, Yanira Florido, Ruth Stuckey, María Nieves Sáez, Santiago Sánchez-Sosa, Jesús María González Martín, Guillermo Santana, Elena González-Pérez, Naylén Cruz-Cruz, Rosa Fernández, Teresa Molero Labarta, María Teresa Gomez-Casares
Published 2020-12-01
Article -
8
PB1754: HOMOZYGOUS DELETION OF ETV6: EARLY T-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA OR PRECURSOR T-LYMPHOBLASTIC LYMPHOMA by Miguel Ángel Perera Álvarez, Juan Francisco Rodríguez López, Jorge Rodríguez-Afonso, Paula Reyes-González-Casanova, Dolly Viviana Fiallo Suarez, Maria Angelina Lemes Castellano, Maria Violeta Vidal Ballester, Ruth Stuckey, Carlos Rodriguez Medina, Cristina Bilbao, Maria Teresa Gomez Casares
Published 2023-08-01
Article -
9
Genetic Testing at Diagnosis Has Prognostic Value in Patients with Chronic Lymphocytic Leukemia including at Early Stages by Alexia Suárez-Cabrera, Dolly Viviana Fiallo-Suárez, Ruth Stuckey, Marta Luna Uroz-de la Iglesia, Yanira Florido, Angelina Lemes-Castellano, Miguel Ángel Perera-Álvarez, Hugo Luzardo-Henríquez, Haridian de la Nuez, Paula Fernández-Caldas, Silvia de la Iglesia, María Teresa Gómez-Casares, Cristina Bilbao-Sieyro
Published 2022-07-01
Article -
10
PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase. by Juan M Alonso-Dominguez, Luis Felipe Casado, Eduardo Anguita, Maria Teresa Gomez-Casares, Ismael Buño, Francisca Ferrer-Marín, Alicia Arenas, Rafael Del Orbe, Rosa Ayala, Pilar Llamas, Rocio N Salgado, Santiago Osorio, Pedro Sanchez-Godoy, Carmen Burgaleta, Ignacio Mahíllo-Fernández, Valentin Garcia-Gutierrez, Juan Luis Steegmann, Joaquín Martinez-Lopez
Published 2017-01-01
Article -
11
The Cardiovascular Event Risk Associated with Tyrosine Kinase Inhibitors and the Lipid Profile in Patients with Chronic Myeloid Leukemia by María Nieves Saez Perdomo, Ruth Stuckey, Elena González-Pérez, Santiago Sánchez-Sosa, Paula Estupiñan-Cabrera, Sunil Lakhwani Lakhwani, José David González San Miguel, Nuria Hernanz Soler, Marina Gordillo, Gloria González Brito, María Tapia-Torres, Ana Ruano, Adrián Segura-Díaz, Hugo Luzardo, Cristina Bilbao-Sieyro, María Teresa Gómez-Casares
Published 2024-03-01
Article -
12
Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation by Alberto Alvarez-Larrán, Arturo Pereira, Paola Guglielmelli, Juan Carlos Hernández-Boluda, Eduardo Arellano-Rodrigo, Francisca Ferrer-Marín, Alimam Samah, Martin Griesshammer, Ana Kerguelen, Bjorn Andreasson, Carmen Burgaleta, Jiri Schwarz, Valentín García-Gutiérrez, Rosa Ayala, Pere Barba, María Teresa Gómez-Casares, Chiara Paoli, Beatrice Drexler, Sonja Zweegman, Mary F. McMullin, Jan Samuelsson, Claire Harrison, Francisco Cervantes, Alessandro M. Vannucchi, Carlos Besses
Published 2016-08-01
Article -
13
Application of IPSET-thrombosis in 1366 Patients Prospectively Followed From the Spanish Registry of Essential Thrombocythemia by Alberto Alvarez-Larrán, Beatriz Cuevas, Patricia Velez, Soledad Noya, Gonzalo Caballero-Navarro, Francisca Ferrer-Marín, Sara Carbonell, Manuel Pérez-Encinas, María Teresa Gómez-Casares, Raúl Pérez-López, Elena Magro, Ana Moretó, Irene Pastor-Galán, Anna Angona, María Isabel Mata-Vázquez, Lucía Guerrero-Fernández, José María Guerra, Gonzalo Carreño-Tarragona, Laura Fox, Ilda Murillo, Valentín García-Gutiérrez, Elvira Mora, Ruth Stuckey, Eduardo Arellano-Rodrigo, Juan Carlos Hernández-Boluda, Arturo Pereira, On behalf of the MPN Spanish Group (GEMFIN)*
Published 2023-08-01
Article -
14
Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea by Alberto Alvarez-Larrán, Manuel Pérez-Encinas, Francisca Ferrer-Marín, Juan Carlos Hernández-Boluda, María José Ramírez, Joaquín Martínez-López, Elena Magro, Yasmina Cruz, María Isabel Mata, Pilar Aragües, María Laura Fox, Beatriz Cuevas, Sara Montesdeoca, José Angel Hernández-Rivas, Valentín García-Gutiérrez, María Teresa Gómez-Casares, Juan Luis Steegmann, María Antonia Durán, Montse Gómez, Ana Kerguelen, Abelardo Bárez, Mari Carmen García, Concepción Boqué, José María Raya, Clara Martínez, Manuel Albors, Francesc García, Carmen Burgaleta, Carlos Besses
Published 2017-01-01
Article -
15
Validation of mutated <i>CEBPA</i> bZIP as a distinct prognosis entity in acute myeloid leukemia: a study by the Spanish PETHEMA registry by Esther Prados de la Torre, Josefina Serrano, David Martínez-Cuadrón, Laura Torres, Claudia Sargas, Rosa Ayala, Cristina Bilbao-Sieyro, María Carmen Chillón, María José Larráyoz, Elena Soria, Clara Aparicio-Pérez, Juan M. Bergua, Teresa Bernal, Cristina Gil, Mar Tormo, Lorenzo Algarra, Juan M. Alonso-Domínguez, Eduardo Rodriguez-Arbolí, Pilar Martínez-Sanchez, Ana Oliva, Ana M. Colorado-Araujo, Carlos Rodríguez-Medina, Susana Vives, Lourdes Hermosín, Joaquín Martínez-López, Ramón García-Sanz, José A. Pérez-Simón, María José Calasanz, María Teresa Gómez-Casares, Eva Barragán, Joaquín Sánchez-García J, Pau Montesinos
Published 2024-04-01
Article -
16
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis by Adrián Mosquera-Orgueira, Manuel Pérez-Encinas, Alberto Hernández-Sánchez, Teresa González-Martínez, Eduardo Arellano-Rodrigo, Javier Martínez-Elicegui, Ángela Villaverde-Ramiro, José-María Raya, Rosa Ayala, Francisca Ferrer-Marín, María-Laura Fox, Patricia Velez, Elvira Mora, Blanca Xicoy, María-Isabel Mata-Vázquez, María García-Fortes, Anna Angona, Beatriz Cuevas, María-Alicia Senín, Angel Ramírez-Payer, María-José Ramírez, Raúl Pérez-López, Sonia González de Villambrosía, Clara Martínez-Valverde, María-Teresa Gómez-Casares, Carmen García-Hernández, Mercedes Gasior, Beatriz Bellosillo, Juan-Luis Steegmann, Alberto Álvarez-Larrán, Jesús María Hernández-Rivas, Juan Carlos Hernández-Boluda, on behalf of the Spanish MPN Group (GEMFIN).
Published 2023-01-01
Article -
17
Integrating AIPSS‐MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis by Adrián Mosquera‐Orgueira, Eduardo Arellano‐Rodrigo, Marta Garrote, Iván Martín, Manuel Pérez‐Encinas, María‐Teresa Gómez‐Casares, Alberto Hernández‐Sánchez, Francisca Ferrer‐Marín, Elvira Mora, Patricia Velez, Rosa Ayala, Anna Angona, Natalia de las Heras, Elena Magro, Carlos Pérez‐Míguez, Davide Crucitti, María‐Isabel Mata‐Vázquez, María‐Laura Fox, Sonia González de Villambrosía, María‐José Ramírez, Ana García, Valentín García‐Gutiérrez, Amparo Cáceres, María‐Antonia Durán, María‐Alicia Senín, José‐María Raya, José A. González, Beatriz Cuevas, Blanca Xicoy, Jyoti Nangalia, Jesús M. Hernández‐Rivas, Beatriz Bellosillo, Alberto Álvarez‐Larrán, Juan C. Hernández‐Boluda, Spanish MPN Group (GEMFIN)
Published 2024-03-01
Article -
18
PB1779: FLT3-ITD MUTATION CHARACTERIZATION WITH CLASSICAL PCR METHODOLOGY VERSUS CAPTURE- AND AMPLICON-BASED NGS PLATFORMS: A PETHEMA NGS-AML PROJECT by Cristina Bilbao, Ruth Stuckey, Claudia Sargas, María J Larráyoz, Maria Carmen Chillon, Rosa Ayala Diaz, Estrella Cruz Carrillo, Manuel Yébenes-Ramírez, David Martinez-Cuadron, Rebeca Rodriguez-Veiga, Cristina Gil, Teresa Bernal, Juan Miguel Bergua Burgues, Lorenzo Algarra, Mar Tormo, Maria Pilar Martinez Sanchez, Elena Soria Saldise, Josefina Serrano, Juan Manuel Alonso Dominguez, Raimundo Garcia Boyero, Maria Luz Amigo, Pilar Herrera-Puente, Maria J Sayas, Esperanza Lavilla Rubira, Carlos Rodriguez Medina, Santiago Sánchez Sosa, Jorge Rodríguez-Afonso, Paula Reyes-González-Casanova, Eduardo Rodríguez-Arbolí, Joaquin Sanchez Garcia, Joaquín Martinez-Lopez, Ramón García-Sanz, Maria Jose Calasanz, Eva Barragan, Maria Teresa Gomez Casares, Pau Montesinos
Published 2023-08-01
Article -
19
Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Im... by Nerea Vega-García, Nerea Vega-García, Sara Perez-Jaume, Elena Esperanza-Cebollada, Elena Esperanza-Cebollada, Clara Vicente-Garcés, Clara Vicente-Garcés, Montserrat Torrebadell, Montserrat Torrebadell, Montserrat Torrebadell, Antonio Jiménez-Velasco, Margarita Ortega, Marta Llop, Marta Llop, Lorea Abad, José Manuel Vagace, Alfredo Minguela, Marta Pratcorona, Joaquín Sánchez-Garcia, Clara B. García-Calderón, María Teresa Gómez-Casares, Estela Martín-Clavero, Adela Escudero, Marta Riñón Martinez-Gallo, Luz Muñoz, María Rosario Velasco, Marina García-Morin, Albert Català, Albert Català, Albert Català, Antonia Pascual, Pablo Velasco, José Mª. Fernández, Alvaro Lassaletta, José Luis Fuster, Isabel Badell, Águeda Molinos-Quintana, Antonio Molinés, Pilar Guerra-García, Pilar Guerra-García, Antonio Pérez-Martínez, Antonio Pérez-Martínez, Miriam García-Abós, Reyes Robles Ortiz, Sandra Pisa, Rosa Adán, Cristina Díaz de Heredia, José Luis Dapena, José Luis Dapena, Susana Rives, Susana Rives, Susana Rives, Manuel Ramírez-Orellana, Mireia Camós, Mireia Camós, Mireia Camós
Published 2021-02-01
Article